Delivery Order SPE2DB20D7059-SPE2DB24FQDW9
Award Date 4/22/24
Potential Completion Date 4/23/24
Potential Value $16K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of Advair HFA 45-21 MCG Inhaler 12GM, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The contract has a total ceiling value of $16,092.00 and was awarded on a Firm Fixed Price basis. It is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued up to $999,999,999.00 through December 31, 2025....
- This federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of Advair HFA 230-21 mcg inhaler 12 gm to the Defense Logistics Agency (DLA). The contract has a ceiling value of $7,153.38 and a completion date of June 27, 2024. It is a delivery order contract with a firm fixed price pricing type. The contract is not set aside for any specific business category. Amerisourcebergen holds a significant Indefinite...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of Advair HFA 230-21 MCG Inhaler (12 gm) to the Defense Logistics Agency (DLA). The $4,126.33 firm fixed-price delivery order is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to provide a...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the purchase of Advair HFA 45-21 MCG Inhaler 12GM. The contract has a ceiling value of $6,408.23 and a completion date of January 8, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, for the delivery of an Advair HFA 230-21 mcg inhaler product. The Delivery Order contract, valued at $1,987.86, is a Firm Fixed Price arrangement with a completion date of May 22, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with DLA Troop Support Medical, valued up to $999,999,999.00...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Advair HFA 115-21 MCG inhalers, with a ceiling value of $1,104.35 and a completion date of April 1, 2025. The contract is a Delivery Order and is priced as Firm Fixed Price. This award is not associated with a set-aside program. Amerisourcebergen Drug Corp holds a significant Indefinite...
- This federal contract award is for the delivery of Advair HFA 230-21 mcg inhalers to the Defense Logistics Agency (DLA). The contract has a ceiling value of $8,671.68 and is a firm fixed price delivery order. The prime contractor is AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract does not have a set-aside designation. The ultimate completion date is August 28, 2024. This contract is likely part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of Advair HFA 230-21 MCG Inhaler, a prescription pharmaceutical product, to the Department of Defense (DoD) and Defense Logistics Agency (DLA). The contract, valued at $18,550.39, is a delivery order under an existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a ceiling value of up to $999,999,999.00 through December 31, 2025. This single-award IDC...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of Advair HFA 230-21 MCG Inhaler 12GM pharmaceutical products to the Defense Logistics Agency (DLA). The $2,782.02 Firm Fixed Price contract, which does not have a set-aside designation, is a Delivery Order issued under Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This single-award IDC...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Advair HFA 115-21 MCG Inhaler 12GM. The contract has a ceiling value of $3,123.96 and a completion date of February 29, 2024. It is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC, valued at up to...
- SPE2DB20D7059Indefinite Delivery Contract
- SPE2DB20D7059-SPE2DB24FQDW9Delivery Order
This federal contract award is to Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical distributor, to provide Advair HFA 230-21 mcg inhaler 12 gm to the Defense Logistics Agency (DLA). The contract has a ceiling value of $16,019.00 and a completion date of April 23, 2024. This appears to be a delivery order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA, valued up to $999,999,999.00 through December 2025. The IDC allows the DLA to efficiently procure a wide range of pharmaceutical products and medical supplies for the Department of Defense. This specific award is not designated as a set-aside contract.
Generated 7/22/24, 9:13 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $16.0k | 4/22/24 |